Mesothelioma is a specific and deadly type of lung cancer that is caused by exposure to asbestos. This Mesothelioma Blog was created to provide a single source to locate information on mesothelioma medical and legal resources for patients, families, and friends in need. We hope that our mesothelioma search engine can provide what you need, but if not we are always ready to help if we can.
Drugs Investigator Accuses Government of Gross Wastage of Taxpayers Money
Psycho-Pharmaceutical Scam Revealed as NHS Spending Rockets Over-Budget
[ClickPress, Sun Feb 26 2006] Drug addicts, NHS patients and U.K. students are suffering through ineffective long-term treatments whilst the government lines the pockets of psychiatrists and pharmaceutical companies with British taxpayers money, declared Kenneth Eckersley the Founder of CEPTA the Campaign for Effective Prevention & Treatment of Addiction at last months Brussels drugs conference and at recent U.K. venues.
He went on to point out that whilst the cost of buildings, equipment and personnel had been blamed for NHS over-spending, the truth is that it is the increasing proliferation of pharmaceutical drug prescribing which is the main cause of massive budget over-spending and wastage.
He went on Wastage, because in many cases there is no evidence that the drugs actually achieve the results for which they are prescribed. Wastage, because in many cases the drugs produce side-effects which require the prescription of additional drugs. Wastage because an increasing number of drugs are being developed and prescribed not with the intention of curing the patients problem, but with the nearly criminal intent of creating a life-long drugs consumer in continuous treatment, and because virtually no-one gets cured, the numbers of patients to be treated with more and more drugs escalates every year.
This is done Eckersley alleges by the psycho-pharm fraternity convincing successive governments that more and more human conditions are not really susceptible to a cure as they are essentially mental illnesses which (they fortuitously claim) can only be treated by managing the condition with pharmaceutical drugs. He points out that under the N.H.S. such drugs are of course paid for by the taxpayer, and that psycho-pharmaceutical marketing strategies are set up to take advantage of this.
ONE EXAMPLE OF THIS ALLEGED SCAM:
It is 60 years since the psycho-pharmaceutical fraternity sold politicians the false idea that heroin addiction was incurable and that they must therefore put such addicts on a methadone programme which (because 89% of such users are unemployed) would have to be paid for by the taxpayers.
Eckersley explained that, depending on the size of dose, the methadone cost per addict per day is between £3.50 & £5.00, and averages £4.00. With at least 350,000 addicts on prescribed methadone, the cost per day is therefore some £1.4 Million over £510 Million (half a Billion) per year.
But, he says, the cost to the taxpayer doesnt stop there. Because of its many side-effects and the debilitating main effect of the drug itself, it seems numerous general practitioners are reluctant to prescribe methadone, as a result of which the psycho-pharms have persuaded government to pay doctors a prescribing commission, and, of course, high street pharmacists also receive a dispensing fee.
With so many methadone users unemployed, most of them are drawing Unemployment Benefit every week, along with Income Support, Housing Allowance and Child Support. Furthermore, they take up more public resources and the time of police, the NHS, probationary officers and the Courts. More needless waste of Billions of tax money says Eckersley.
When asked What Does the Taxpayer Get Back in Return? Ken Eckersley reports that government was told an addict on a methadone prescription would no longer use his illegal drug of choice, and so would no longer need to carry out acquisitive crimes to feed his habit. But says Ken the BIG ISSUE in The North research into Drugs at the Sharp End revealed that 80% of legal methadone addicts use another drug (usually heroin or cannabis) once a week and that 44% use heroin once a day.
As a result he says they continue with a life of crime to maintain their drug supplies, and it is obvious that they consider their daily methadone merely as a free supply for which, via The Alliance (a psycho-pharmaceutically supported pressure group) they keep campaigning for bigger doses at shorter intervals - at further taxpayer expense of course.
The total direct and indirect cost of the methadone programme provably runs into many Billions Ken argues yet does nothing but exacerbate the drugs problem as it fails miserably to cure any addict of his or her habit. He goes on to point out that this is also true of the psycho-pharmaceutical schools prescription programme for so-called ADHD, etc., and is true of tranquilliser / benzodiazepine prescribing to older citizens.
Finally he indicates that psycho-pharmaceutical marketing strategies all follow the same formula: To make sure we get paid, sell in bulk to the Government, so that they can give free supplies for life, to more and more different groups of citizens all at taxpayer cost of course!
About C.E.P.T.A. To create a drug-free society we need only to cure existing addicts whilst ensuring that no more youngsters take up drug usage. This means developing and promoting EFFECTIVE prevention and EFFECTIVE cures.
C.E.P.T.A. came into being when studies revealed that effective prevention and treatment had already existed in various countries for over 50 years, but were being suppressed in Europe, not only by producers and traffickers of illicit drugs, but also by commercial interests whose production levels and profitability depend upon increasing the sale of all forms of drugs, with no regard to the increasing number of addicts thus threatening our society.
C.E.P.T.A. (The Campaign for the Effective Prevention & Treatment of Addiction) was therefore founded by concerned E.U. citizens for the purpose of contradicting and exposing vested interest political lobbying and misleading P.R. campaigns which deliberately hide the failure to cure of current psycho-pharmaceutical treatments whilst also promoting drug liberalisation via so-called harm reduction and related drugs education - instead of providing real prevention training.
For more information, contact:
Ken Eckersley C.E.P.T.A. The Campaign for the Effective Prevention & Treatment of Addiction ARTS House Plaw Hatch Lane Sharpthorne East Grinstead West Sussex RH19 4JL Phone & Fax: +44 01342 811099 24 Hour Answering Service. e-mail: email@example.com Web: http://www.solutionstodrugs.com
Submitted by: John Wood UpTone PR East Grinstead West Sussex 0777 152 0001 firstname.lastname@example.org http://www.uptone.co.uk
Addiction, Drug Addiction, addiction treatment, crime, drugs, prescription drug, health care cost, methadone, heroin, NHS, patient, pharmaceutical, psychiatrists, rehabilitation, scam, side-effects, tax, taxpayer, unemployment, wastage, overspending, prescribing, state-support
There Is Unknown Information On Mesothelioma Treatments
JustMeso Offers Information on Treatment Options
JustMeso.com offers a plethora of information on treatment options for mesothelioma.
(I-Newswire) - Mesothelioma, the deadly disease that has been at the forefront of global medical and legal research for the last decade, is becoming increasingly susceptible to advanced treatment options. While the disease is not yet curable, if caught very early there are a wide range of rather divergent medical treatment options which have had substantial success in limiting the harmful effects of malignant mesothelioma.
While there are a number of treatment options available, often there is a great deal of unknown information regarding what the procedures available are and how they work. To that end, JustMeso.com ( http://www.JustMeso.com ) has provided comprehensive information about the disease, its causes, and now the treatment options available to those diagnosed at its website.
The site explains in great detail the many traditional and new treatments available to those diagnosed with malignant mesothelioma, such as surgical solutions, radiation, and chemotherapy. JustMeso.com breaks down each category into its component procedures as well as providing information on the extent of a procedure, its level of invasiveness, as well as an analysis of the costs and benefits of each specific procedure. This analysis includes summaries of information on the effectiveness and the scope of the effectiveness of a particular treatment option.
Combined, the information compiled by JustMeso.com in their treatment options section ( http://www.justmeso.com/treatment/ ), provides those diagnosed as well as their loved ones with a comprehensive resource from which they can attain a deeper understanding of the diseases as well as assess either own situation in light of the present treatment options available. This information can prove valuable insofar as it will give individuals an excellent overview of the options available to them. Through this information, individuals affected by mesothelioma can make more educated decisions about their own situation as well as be better situated to provide support for others. Of course, none of the information on JustMeso should be taken as medical advice, and a person should always consult their physician before taking treatment.
JustMeso.com ( http://www.JustMeso.com ) is based in the United States. It was created with the intent of providing a single resource for individuals seeking information about malignant mesothelioma.
If you have questions regarding information in this press release contact the company listed below. I-Newswire.com is a press release service and not the author of this press release. The information that is on or available through this site is for informational purposes only and speaks only as of the particular date or dates of that information. As some companies / PR Agencies submit their press releases once per week/month or quarter, make sure check the official company website for accurate release dates as our site displays the I-Newswire.com distribution date only. We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for inaccuracies or omissions in that information or for actions taken in reliance on that information.
Mesothelioma Search Engine To Consolidate Medical and Legal Information
New lung cancer search engine provides information on medical and legal web sites for those researching this asbestos-caused killer cancer
Minneapolis, MN (NTS) February 23, 2006 On the one-year anniversary of the launch of their Vioxx Search Engine, Internet consulting firm Nielsen Technical Services today announced the launch of their Mesothelioma Search Engine.
Niche search engines or vertical search engines have increased in popularity, but the time and expense of creating and maintaining a search engine for a highly vertical segment of an available search audience is generally not a good investment financially. When asked about the financial viability of such a site, owner Chris Nielsen said, We have some interested parties that would like to be associated with us and are exploring those options, but will not compromise our values for the sake of making a buck. The massive amount of money the asbestos and mesothelioma lawyers are spending have resulted in a feeding frenzy which has spawned thousands of sites and millions of pages of fluff, trash, and recycled content. I admit our site is expected to carry ads at some point, but that is not the reason for creating the site.
Nielsen was then asked the reason for creating such a site. I just could not find a central source to go for information where sites were not bidding or competitively optimizing for position and search engine ranking. Search engines are fighting to maintain relevancy but they are having problems. Many scraper sites are only looking to get visitors that will click on ads to reach real content. If you try a search for mesothelioma it should be clear what the problem is.
As with their Vioxx medical and legal search engine, Mesothelioma Search Engine will carry no paid search engine results or paid inclusion of sites. The site has a form for visitors to suggest sites. The list of sites included in the index is posted on the site and clearly shows mesothelioma site owners if their site has been included. It is also available for download, a feature not offered by other search engines.
The company is indexing selected sites for those looking for more information such as patients, researchers, families, doctors, pharmacists, students, and those in the legal profession. This site is offered as a public service for those looking for information related to medical and legal information on mesothelioma lung cancer, or asbestos lung cancer for which there is no cure and is caused by exposure to asbestos fibers or asbestos dust.
About Nielsen Technical Services The company is based in Minneapolis, Minnesota and has been providing computer and software services since 1988. The Internet has transformed the company from a hardware services company into Internet consulting and specializes in search engine optimization.
Kennedy Statement On Asbestos Legislation Endorsed
Mesothelioma-attorney-case.com endorses kennedy statement on asbestos legislation.
Senator Edward Kennedy issued a key statement today regarding Bill S.852 the Fairness in Asbestos Injury Resolution Act of 2005. Kennedy's statements coincide with our previous opinion regarding the pending bill.
(I-Newswire) - Senator Edward Kennedy issued a key statement regarding Bill S.852 the Fairness in Asbestos Injury Resolution Act of 2005. Kennedy's statements coincide with our previous opinion regarding the pending bill.
The real crisis regarding asbestos exposure in the workplace is not potential litigation but the number of victims who contract the deadly disease Mesothelioma.
Supporters of the bill propose to set up a $140 billion dollar asbestos compensation fund, but it is doubtful if even an all out effort this week will bring the bill to a vote on the floor of the US Senate.
As Kennedy states victims suing the companies who exposed their loved ones to this disease did not create the costs. The costs, which include lost productivity, medical, care, along with payments to provide basic living needs for family members who died years before their time.
A shifting of financial burden to the victims and their families is, according to Kennedy unacceptable.
Kennedy recognizes the efforts by Senators Specter and Leahy who are in favor of passage of the bill. That said it has several fundamental flaws, which make it an unreasonable solution to the pending crisis.
Kennedy states our first obligation is to do no harm. Argument that there are certain inadequacies regarding how current asbestos litigation is handled should not be the major thrust toward passage of this bill.
Government intervention is the concern voiced across the nation by potential victims of this deadly disease. If the fund were to liquidate over time all potential damages would be in question. What rights would victims have in a legal setting to seek compensation from the offending companies?
Individuals concerned about their risks of legal passage of Bill S.852 can use the www.mesothelioma-attorney-case.com Legal Information page ( http://www.mesothelioma-attorney-case.com/legalissues.html ) to better understand the ramifications of the legal act. To gain more knowledge regarding the use of asbestos and the contraction of the disease see our research of Asbestos page ( http://www.mesothelioma-attorney-case.com/research.html ).
Asbestos Trust Fund Opposed By Mesothelioma Medical Experts
Mesothelioma Medical Experts Oppose Asbestos Trust Fund, Saying FAIR Act Hurts More than Helps
NEW YORK, Feb. 9 /PRNewswire/ -- The Doctor-Patient Alliance for Responsible Asbestos Policy today repeated its call on the U.S. Senate to cure fatal flaws in the proposed Asbestos Trust Fund bill (SB 852).
Last July, the nationwide group of 34 doctors who treat mesothelioma patients urged the U.S. Senate to remove the "one-size-fits-all" cap on awards and install a due process hearing, at which patients could prove their special medical and financial hardship damages and have their award tailored accordingly. The claims review system would be modeled after the 9/11 Victims Compensation Fund.
In addition, the Doctor-Patient Alliance asked for assurances that dying mesothelioma patients would be fairly compensated during their shortened life span. The detailed letter was sent to all 100 U.S. Senators.
"We are disappointed that our suggestions were ignored," said Dr. Harvey Pass, Chief of Thoracic Surgery at New York University Medical School. "This bill presented an historic opportunity to enact legitimate reforms that would directly benefit present and future meso patients. Regrettably, the bill actually hurts more than helps meso patients."
"The $1.1 million cap is insufficient to meet the medical, hospital, travel, lodging and other costs of mesothelioma patients who pursue the best treatments, which include surgery, chemotherapy, radiation, or a combination of therapies," said Dr. Robert Cameron, Chief of Thoracic Surgery at UCLA Medical School. "The inflexible cap fails to address the ongoing medical costs of patients who survive long enough to outlive the median survival time but who remain disabled and unable to earn a living. The bill ends up discriminating against the early stage, usually younger, patients whose life- long medical costs are certain to exceed their award.
"Mesothelioma must be treated as a chronic disease that requires a lifetime of care and treatment," said Dr. Cameron. "The costs of staying alive will far surpass the bill's arbitrary cap. Worse, some patients may decide against expensive novel treatments to stockpile the meager 'compensation' for their family."
In addition, the Alliance argues that any awards should be made while the money can be effectively invested in life-extending cures. "I doubt very much that the new bureaucracy will be up and running within my life time," predicts Dr. Bret Williams, age 52, a two year meso survivor who has incurred over $600,000 in medical bills. "It will take at least two years for the new federal agency to start paying out claims, while the median survival for mesothelioma patients is about nine months."
Dr. Williams, who has resolved his third-party civil claim, noted that most states have laws that allow in extremis meso patients to obtain preferential trial settings. For example, in Colorado and California, courts are required to set hardship meso cases for trial within 120 days. "I don't buy the rhetoric that an untested, under funded and at this point non-existent federal agency will pay out fair compensation faster than the court system," said Dr. Williams.
The Doctor-Patient Alliance has concerns that the bill will unduly restrict access to the Fund based on industry-friendly exposure criteria. "The Bill provides only for those with prolonged, occupational exposure. It excludes those with neighborhood exposure, or exposure only in schools or homes or while doing 'shade tree mechanic' work. It completely knocks out the first responders to the World Trade Center collapse," said Dr. Williams.
"My family would not have been compensated under the Trust Fund, since I was exposed while doing sporadic home repairs and while working with vermiculite potting soil," noted Dr. Williams.
"The U.S. Senate should correct these serious flaws or start over," said Dr. Pass. "Our government must do better when it comes to federal compensation initiatives. Recent studies of similar programs, like the Black Lung fund, make me skeptical that the asbestos trust fund will work. The motives may have been noble, but every federal compensation program to date has been marred by much higher costs, more claims than predicted, serious delays in meeting the demand and long intervals between the date the bill became law and the day the government started writing checks."
"I have a message for Dr. Frist," said Dr. Williams. "We belong to a privileged profession. Years ago, we dedicated ourselves to healing the sick, to caring for people from all occupations. It's been said that politics is 'medicine on a grand scale.' The principles guiding patient care should inform your decisions today. Let's ban asbestos. Let's fund research on effective treatments to stave off the asbestos health crisis. But let's not bail out industry at the expense of victims. Dr. Frist, do no harm."
For more information, see http://www.drpatientalliance.org/ . Contact: Dr. Harvey Pass Dr. Robert Cameron Chief of Thoracic Surgery Chief of Thoracic Surgery NYU School of Medicine UCLA Medical Center email@example.com firstname.lastname@example.org 212-263-7417 310-794-7333 Dr. Bret Williams, survivor Klaus Brauch, survivor Hillsborough, N.C. Huntington Beach, CA email@example.com firstname.lastname@example.org 919-732-4656 714-969-1481
Cure For Mesothelioma Aided By $1 Million of Research Funding
New Research Grants Continue Progress Against Dread Cancer
Mesothelioma Applied Research Foundation Announces Additional $1 Million of Research Funding
SANTA BARBARA, Calif., Feb. 23 /PRNewswire/ -- The Mesothelioma Applied Research Foundation ("MARF") announced today awards of almost $1 million in additional research funding aimed at curing mesothelioma ("meso"). An international and cross disciplinary set of nine new projects will go forward thanks to grants from MARF of $100,000 each. Researchers in Holland, Australia and the United States combined their efforts to field a broad spectrum of investigative efforts that are certain to advance the pace and scope of research success against this deadly cancer. Meso is a malignant tumor related to asbestos exposure that aggressively invades the mesothelial linings of the lungs, abdomen, heart, or testicles.
MARF's scientific experts selected the nine projects as the most important and promising among 28 high caliber applications received from around the world. For each of these two-year projects, the researchers are bound by strict budgeting and progress reporting requirements. Funds for the first year were paid in late 2005 and the research is now underway.
In a Phase I clinical trial focused on immune therapy, Doctor B.N.M. Lambrecht of the Erasmus Medical Center in Rotterdam, the Netherlands, plans to evaluate dendritic cells as a therapeutic adjuvant for treating malignant meso in humans. This grant follows up on previous successes with immunotherapy studies in mice that were very effective and also funded by MARF. Dendritic cells proved capable of generating an immune response when presenting meso tumor antigens and the current study intends to test the feasibility and safety of this approach.
Hot on the heels of meso-specific serum biomarker announcements in late 2004 and early 2005, researchers at USC under the direction of Dr. Ite Laird-Offringa were given a grant to continue investigating diagnostic markers for meso. USC plans to use DNA microarray chips to pre-screen 6500 serum markers using the MethyLight analytical system. Tissue samples would be examined to identify specific molecular markers found in meso tumor specimens with an eye to developing new serum tests to aid early diagnosis of the cancer.
The molecular understanding of the human genome has allowed researchers to undertake much more precise and tactical interventions against meso. Professor Xiaobo Cao of Texas A&M University, and his team, received a grant to investigate a specific gene family bcl-2, known to over-express a protein BCL-XL which blocks cell death (apoptosis) in mesothelioma tumors. Researchers wish to evaluate a bcl-2/bcl-xl antagonist, a compound that blocks the actions of the over-expressed protein, to see if it will cause tumor cell death and sensitize meso cells to the effects of existing chemotherapy agents. Such studies were virtually impossible ten years ago and represent the leading edge of scientific research today.
A Nevada Cancer Institute team under the direction of Dr. Sunil Sharma will continue its investigation of suberoylanilide hydroxamic acid (SAHA), a histone deacetylase (HDAC) inhibitor. SAHA and other HDLC inhibitors have demonstrated broad cancer activity and provide a promising new approach to therapy. Tumor resistance to HDAC inhibitors will be studied in an effort to identify combination therapies with mTOR inhibitors and nutrient uptake inhibitors that can increase tumor response to treatment. Dr. Sharma intends to generate a meso cell line resistant to SAHA and other drugs like valproic acid and then compare them to parent cell lines using molecular analysis to identify markers of resistance. These markers will then become targets for therapy.
MARF funded five other, equally innovative and important studies in this latest round of grants. Some of these research grants will become stepping stones; used to provide sufficient data to propose and win larger research grants from the National Institute of Health (NIH) and other government agencies. Using this approach, MARF-funded projects have had a multiplier effect on the total research investment into a cure for mesothelioma. Taken together, these studies have achieved, and will continue to achieve, results far in excess of what MARF could have accomplished alone. Without MARF's investment, however, little progress would have taken place.
For more information, contact MARF, the national nonprofit whose mission is to eradicate mesothelioma as a life-ending disease: http://www.marf.org; Executive Director Chris Hahn, 805-560-8942, email@example.com; or Communications Director Klaus Brauch, 714-969-1481, firstname.lastname@example.org.
April 19, 2005 - AUSTRALIAN researchers have developed a world-first blood test which could help in the early detection of mesothelioma, a deadly asbestos-related cancer of the lung lining.
About 700 people every year are diagnosed with the disease in Australia, which has the highest reported incidence in the world.
It can take up to 30 years for symptoms of the condition to develop so most sufferers are identified at an advanced stage and die within a year.
The non-invasive blood test developed by University of Western Australia Professor Bruce Robinson and a team of researchers is a breakthrough in the early detection of mesothelioma.
Under existing arrangements, diagnosis is a long process which includes blood tests, chest x-rays, CT scans, drainage and laboratory analysis of the pleural fluid to help differentiate mesothelioma from other similar conditions.
The new blood test, named MESOMARK, was originally developed for cervical cancer at the Pacific Northwest Research Institute in the US, but Professor Robinson has adapted it for testing mesothelioma.
Dr Nick Pavlakis, a leading mesothelioma researcher in Sydney, said the blood test would be a valuable diagnostic aid for doctors.
"The test is a breakthrough because it's a simple blood test, it could therefore be applied to patients who are at risk, those who have a history of exposure or symptoms of the disease," he said.
The blood test measures the amount of protein in the blood, and a patient who returned a low reading would register a negative result.
But if the patient returned a high reading they would be sent for a second test to confirm the result.
Former painting contractor Erl Carlsson, who has mesothelioma, said the test would be valuable in monitoring the health of his family.
Mr Carlsson, 59, who lives in Narrabeen, on Sydney's northern beaches, was diagnosed with the disease in October last year after 30 years of sanding back asbestos fibro in his work as a painter.
He is now concerned for the health of his wife Barbara, who washed his clothes with asbestos dust on them, and children Andrew, 31, and Jenny, 32, who often worked with him when they were younger.
"It would really help the treatment, it's usually 20 or 30 years before you find out you have it ... it could have helped me too," Mr Carlsson said.
Dr Pavlakis said the amount of people diagnosed with the disease was expected to peak between 2010 and 2020 when the symptoms had fully developed.
"What we are seeing today is a product of exposure decades ago, so even though the legislation changed to reduce occupational exposure to asbestos fibres we have a decade lag time between the exposure and the disease," he said.
Symptoms for mesothelioma include breathlessness and chest pain.
Treatment, including chemotherapy, radiotherapy and surgery, aims to prolong life and keep the person as comfortable as possible.
Acupuncture without Needles Often Out-Performs Pain Relief Drugs
Pain Relief - New Acupuncture without Needles Technique Reports 80% Effectiveness, Often Out-Performing Drugs
Chronic pain, the most costly health problem in America today, often responds within minutes to EFT, a simple do-it-yourself acupressure technique.
San Francisco, CA (PRWEB) February 23, 2006 -- EFT, a new do-it-yourself pain relief procedure has shown remarkable benefits in thousands of clinical applications. Its potential use worldwide may produce major economic breakthroughs in pain management.
For example, chronic pain costs the United States an estimated $50 billion every year, making it the countrys most expensive health problem. An estimated 7 million are partially or completely disabled by back pain, and most adults experience occasional back problems. Arthritis affects 40 million and costs over $4 billion in lost income and health care. Another 45 million suffer chronic, recurrent headaches and spend $4 billion per year on medication.
Prescription drugs provide some relief, but they dont always work, their side effects can be serious, and the pain usually returns.
One promising treatment recognized by the National Institutes of Health is acupuncture, the ancient Oriental practice of inserting needles at key points along energy meridians. Acupuncture works by removing blocks along these meridians, allowing energy to flow freely, relieving pain and other symptoms in the process.
Now a do-it-yourself procedure takes acupuncture to a new level by addressing unresolved emotional issues that contribute to pain. Emotional Freedom Techniques, or EFT, combines gentle fingertip tapping on key acupuncture points with focused thought, effectively reducing and often permanently eliminating chronic pain. According to Its practitioners, EFT is more than 80-percent effective in treating headaches, back pain, cancer pain, arthritis, and pain from other conditions.
Steve Wells, an Australian EFT practitioner, worked with a Vietnam War veteran whose chronic lower back pain disappeared in less than a minute. He spent the remainder of the session trying to bring his pain back, says Wells, but it didnt return. Wells reports similar results for clients with shoulder pain, migraine headaches, knee pain, and other conditions.
According to Stephanie Rothman, CHT, My clients have experienced relief from pain and discomfort from headaches, neck stiffness, PMS, allergies, asthma, fibromyalgia, hiccups, stomach cramps, hangovers, and post-surgical discomfort, using only EFT.
Los Angeles physician Eric Robins, MD, finds that EFT often works when conventional therapies fail. Again and again, he says, patients with chronic pain have unresolved emotional issues or anger thats tied to past traumas. Stress and negative emotions arent just in our heads, they are stored in our bodies, often in skeletal or smooth muscles. Its hard for blood to flow through chronically tensed muscles.
This model, he explains, agrees with the theories of John Sarno, MD, Professor of Rehabilitation Medicine at New York University in New York City and author of the best-selling Healing Back Pain: The Mind-Body Connection and other books. Dr. Sarno treats patients not with drugs or surgery but with anger management.
He sees some of the worse chronic pain patients in the world, says Dr. Robins. Most have been in pain for 10 to 30 years despite surgeries, epidural injections, and years of physical therapy. He teaches them that the cause of their pain is anger and that when they let go of the anger, their pain will disappear. He consistently produces a cure rate thats close to 70 percent in terms of pain and function, and an additional 15 percent are much improved.
Dr. Robins considers EFT the most effective, fastest-acting anger management technique available. Like most doctors, Im always in a hurry, he says. If I can teach EFT to a patient in just a few minutes and completely resolve not only chronic symptoms but their underlying cause, thats terrific. In fact, its phenomenal. Nothing in the pharmaceutical world comes close.
Although most Americans have yet to hear of it, EFT may be the worlds fastest-growing self-help technique. Between 5,000 and 10,000 worldwide including hundreds of health care practitioners download the EFT websites free instruction manual each week, and 175,000 subscribe to its online newsletter.
The EFT website generously offers a EFT Free Get Started Package to the public. It includes the EFT Manual (contains all the basics so you can apply it right away) and a free subscription to its popular online newsletter. It can be freely downloaded at
Significance of Mutations in the Avian Influenza Viruses
Avian Influenza: Significance of Mutations in the H5N1 Virus
GENEVA, Feb. 21 /Xinhua-PRNewswire/ -- Several recent media reports have included speculations about the significance of mutations in H5N1 avian influenza viruses. Some reports have suggested that the likelihood of another pandemic may have increased as a result of changes in the virus.
Since 1997, when the first human infections with the H5N1 avian influenza virus were documented, the virus has undergone a number of changes.
These changes have affected patterns of virus transmission and spread among domestic and wild birds. They have not, however, had any discernible impact on the disease in humans, including its modes of transmission. Human infections remain a rare event. The virus does not spread easily from birds to humans or readily from person to person.
Influenza viruses are inherently unstable. As these viruses lack a genetic proof-reading mechanism, small errors that occur when the virus copies itself go undetected and uncorrected. Specific mutations and evolution in influenza viruses cannot be predicted, making it difficult if not impossible to know if or when a virus such as H5N1 might acquire the properties needed to spread easily and sustainably among humans. This difficulty is increased by the present lack of understanding concerning which specific mutations would lead to increased transmissibility of the virus among humans.
Virtually all the known subtypes of influenza A viruses circulate in some wild birds, most notably wild waterfowl. In these birds, different viruses constantly mingle with each other and frequently exchange genetic material, resulting in a huge pool of constantly changing viruses. Mutations and reassortment events are commonly observed in the affected bird populations.
In animals, some recent evolutionary changes in the H5N1 virus appear to have made control efforts more difficult and further international spread of the virus in birds more likely. Such changes are fully understandable, particularly in view of the exceptionally large number of birds that have been infected with the H5N1 virus and the frequent interactions between infected free-ranging poultry and wild waterfowl.
Studies have shown that H5N1 viruses from the current outbreaks, when compared with viruses from 1997 and 2003, have become progressively more lethal in experimentally infected chickens and mice, and are also hardier, surviving several days longer in the environment. Other studies have shown that the virus is not yet fully adapted to poultry and is continuing to evolve.
Domestic ducks have acquired an ability to resist the disease caused by some strains, and are now capable of excreting large quantities of highly pathogenic virus without showing the warning signs of illness. In endemic countries, this altered role of domestic ducks is now thought to contribute to perpetuation of the transmission cycle. Research conducted in South-east Asia has recently shown that multiple distinct lineages of H5N1 virus have become established in poultry in different geographical regions, indicating the long- term endemicity of the virus in parts of Asia. That research also detected highly pathogenic H5N1 virus in apparently healthy migratory birds.
In birds, one important recent finding has been the remarkable similarity of viruses from recent outbreaks to those isolated from migratory birds that began dying at the Qinghai Lake nature reserve in central China in late April 2005. Evidence is mounting that this event, which resulted in the deaths of more than 6,000 wild birds, signalled an important change in the way the virus interacts with its natural reservoir host.
Unlike the case with mutations of human viruses (some of which have been transient), it appears that some changes have become fixed in viruses circulating in at least some species of wild birds.
Prior to the Qinghai Lake event, the highly pathogenic H5N1 virus was known to cause occasional sporadic deaths in migratory waterfowl, but not to kill them in large numbers or be carried by them over long distances.
Viruses from Qinghai Lake showed a distinctive mutation at one site experimentally associated with greater lethality in birds and mice. Viruses from the most recent outbreaks, in Nigeria, Iraq, and Turkey, as well as from earlier outbreaks in Russia, Kazakhstan, and Mongolia, are virtually identical to Qinghai Lake viruses.
It is considered unusual for an avian influenza virus causing outbreaks in birds to remain this genetically stable over so many months. This finding raises the possibility that the virus -- in its highly pathogenic form -- has now adapted to at least some species of migratory waterfowl and is co-existing with these birds in evolutionary equilibrium, causing no apparent harm, and travelling with these birds along their migratory routes.
If further research verifies this hypothesis, re-introduction of the virus or spread to new geographical areas can be anticipated when migratory birds begin returning to their breeding areas.
The recent appearance of the virus in birds in a rapidly growing number of countries is of public health concern, as it expands opportunities for human exposures and infections to occur. These opportunities increase when the virus spreads from wild to domestic birds, especially when these birds are kept as backyard flocks in close proximity to humans.
To date, no human cases have been linked to exposure to wild birds. Close contact with infected poultry and other domestic birds remains the most important source of human infections.
Some mutations have been detected in human viruses isolated in 2005 and, most recently, in one virus isolated from a fatal case in the January 2006 outbreak in Turkey. Although these mutations were found at the receptor- binding site and involved the substitution of more mammalian-like amino acids, the effect of these changes on transmissibility of the virus, either from birds to humans or from one person to another, is not fully understood. Moreover, recent studies show that these mutations were transient and did not become fixed in the circulating viruses.
Scientists do not presently know which specific mutations are needed to make the H5N1 virus easily and sustainably transmissible among humans. For example, it is not known whether the absence of a specific receptor in humans for this purely avian virus is responsible for the present lack of efficient human-to-human transmission. For this reason, virological evidence of mutational changes must be assessed together with epidemiological information about transmission patterns actually occurring in human populations. This necessity further underscores the importance of close surveillance and thorough investigation during every outbreak involving human cases.
Assessments of the outbreak in Turkey, conducted by WHO investigative teams, have produced no convincing evidence that mutations have altered the epidemiology of the disease in humans, which was similar to the pattern consistently seen in affected parts of Asia. There is no evidence, at present, from any outbreak site that the virus has increased its ability to spread easily from one person to another.
Food Can Treat Many Illnesses As Effectively As Drugs
Science Reveals That Food Can Treat Many Illnesses As Effectively As Drugs
Press Release by: Innovative Healing
Published on openPR 02-20-2006 11:04 am - CET
(openPR) - February 20, 2006 -- Naturopathic doctor, Michael Murray will appear Wednesday, March 15, 2006 as a special guest as a guest on Dr. Liz Lipskis Access to Health Experts interview series to discuss his new book, The Encyclopedia of Healing Foods. Dr. Murray will discuss his work showing that diet plays a major role in both provoking and preventing a wide range of diseases. The presentation will have a special focus on the medicinal properties of food.
During the free one-hour teleseminar Dr. Murray will cover the following topics: using foods to stimulate the bodys natural ability to rejuvenate and heal discovering the role of fiber, enzymes, fatty acids, and other dietary components understanding which food prescriptions will help you safely treat more than 70 specific ailments, including acne, Alzheimers disease, immune system depression, insomnia, migraine headaches, PMS, and rheumatoid arthritis preparing foods safely in order to prevent illness and maximize health benefits
Grounded in rigorous scientific research, the Dr. Michael Murrays interview is expected to offer health-conscious eaters scores of valuable food facts. Dr. Murray is known for his ability to make learning about nutrition fascinating, with historical tidbits and discoveries from the laboratory. And he makes practicing it easy and enjoyable, with tips on selecting, storing, and preparing all kinds of healthful foods, plus quick, inventive, and delicious recipes.
To attend the free Access to Health Experts interviews visit http://innovativehealing.com. Written and audio transcripts are available for purchase after the event from the Innovative Healing Book Store.
About Dr. Murray: Michael T. Murray, N.D. is widely regarded as one of the world's leading authorities on natural medicine. He is a graduate, faculty member, and serves on the Board of Trustees of Bastyr University in Seattle, Washington. Dr. Murray is the co-author of A Textbook of Natural Medicine, the definitive textbook on naturopathic medicine for physicians, as well as the consumer version Encyclopedia of Natural Medicine. He has also written over 20 other books.
About Access to Health Experts: Access to Health Experts is a monthly teleseminar interview series hosted by Liz Lipski, PhD, CCN. The program features interviews with many of the most prominent and authoritative experts in integrative medicine. Dr. Lipski is a nationally-known nutritionist and author of Digestive Wellness (3rd Edition McGraw Hill). Innovative Healing is located in Asheville, North Carolina. For more information visit http://innovativehealing.com.
Web Site provides Information On Asbestos Litigation Headed to the Senate
Bill S.852 - the Fairness in Asbestos Injury Resolution Act of 2005 is facing several obstacles in Capitol Hill this coming week.
(I-Newswire) - Bill S.852 - the Fairness in Asbestos Injury Resolution Act of 2005 is being positioned by lobbyists as the answer to the legal quagmire regarding Mesothelioma litigation. Limited exposure to airborne asbestos fibers can lead to contraction of Mesothelioma.
Supporters of the bill propose to set up a $140 billion dollar asbestos compensation fund, but it is doubtful if even an all out effort this week will bring the bill to a vote on the floor of the US Senate.
Government intervention is the concern voiced across the nation by potential victims of this deadly disease. If the fund were to liquidate over time all potential damages would be in question. What rights would victims have in a legal setting to seek compensation from the offending companies?
That said, mesothelioma-attorney-case.com identifies with those opposed to the passage of Bill S.852 - the Fairness in Asbestos Injury Resolution Act of 2005.
Individuals concerned about their risks of legal passage of Bill S.852 can use the www.mesothelioma-attorney-case.com legal Information page ( http://www.mesothelioma-attorney-case.com/legalissues.html ) to better understand the ramifications of the legal act. To gain more knowledge regarding the use of asbestos and the contraction of the disease see our research of Asbestos page ( http://www.mesothelioma-attorney-case.com/research.html ). On this page mesothelioma-attorney-case.com explains the symptom. Diagnosis along with epidemiology issues regarding contracting Mesothelioma.
In addition, mesothelioma-attorney-case.com explains the treatment options available to those who have contracted the disease, as well as how friends and family can help support the fight against Mesothelioma.
Mesothelioma Outcome Improved With Early Chemotherapy
Early Chemotherapy Improves Outcomes for Mesothelioma
According to a recent article published in the Annals of Oncology, immediate treatment with chemotherapy improves survival rates at one year and provides improved quality of life compared to administering chemotherapy once symptoms occur in patients with malignant mesothelioma.
Malignant pleural mesothelioma is a rare cancer that develops in the tissue that covers the lungs and lines the interior of the chest. The majority of individuals who develop malignant pleural mesothelioma have a history of chronic exposure to asbestos.
The only curative treatment for mesothelioma is surgery. However, more than 70% of patients diagnosed with mesothelioma have advanced disease, which places them beyond the curative benefits of surgery. These patients are treated with chemotherapy following surgery with the main goal of treatment being to extend survival time and improve quality of life.
Researchers from England recently conducted a clinical trial to evaluate different timing of the administration of chemotherapy in patients with malignant mesothelioma. This trial included 43 patients who had undergone surgery and had stable disease symptoms for at least 4 weeks. Approximately half of the patients then received immediate chemotherapy consisting of the regimen referred to as MVP (mitomycin, vinblastine, cisplatin, or carboplatin), while the other half did not receive MVP until disease symptoms occurred.
Overall, patients treated with early chemotherapy had improved outcomes:
Median survival was 14 months for patients treated with immediate chemotherapy, compared with 10 months for those treated with delayed chemotherapy.
At one year, survival rates were 66% for those treated with immediate chemotherapy, compared with 36% for those treated with delayed chemotherapy.
Quality of life was generally better among patients treated with early chemotherapy.
Health resource utilization was comparable between the two groups of patients.
The researchers concluded that chemotherapy prior to the onset of disease symptoms improves outcomes compared to administering chemotherapy once symptoms have occurred in patients with mesothelioma. Patients with mesothelioma may wish to speak with their physician regarding their individual risks and benefits of chemotherapy timing.
Reference: OBrien M, Watkins D, Ryan C, et al. A Randomised Trial in Malignant Mesothelioma (M) of Early (E) Versus Delayed (D) Chemotherapy in Symptomatically Stable Patients: the MED Trial. Annals of Oncology. 2006;17:270-275.
Asbestos Cancer Case Piperfitter Awarded $1 Million
SF Jury Awards $1,083,000 in Asbestos Cancer Case
A SF jury awarded $1,083,000 to a pipefitter with asbestosis and colon cancer caused by his work exposure to asbestos. He was represented by the law firm of Brayton Purcell.
San Francisco, CA (PRWEB) February 18, 2006 -- A jury has awarded $1,083,000 to Merle Sandy, a 60yearold retired pipefitter suffering from asbestosis and colon cancer caused by his onthejob exposure to asbestos. Asbestosis is a painful scarring of the lungs that causes shortness of breath and reduced lung capacity. It is not curable. Mr. Sandy underwent surgery for the colon cancer, but the tumor has spread to his liver and his condition remains serious.
The defendant, Exxon Mobil Corporation, is the former owner and operator of an oil refinery located in Benicia, California, where Merle Sandy did industrial maintenance work. He was exposed to dangerous levels of asbestos while removing insulation and working with asbestos gaskets, packing and welding blankets.
Employed by an independent contractor, Mr. Sandy worked at the Benicia refinery from 1970 through 1974. He also worked at the refinery in 1977 and 1979. Although Exxon Mobil personnel oversaw Mr. Sandys work, the company did not disclose that the products he was working with were hazardous, or provide information about the location of asbestos at the refinery, the plaintiff said. Exxon Mobil also did not instruct Mr. Sandy about how to work safely to prevent asbestos exposure or provide him with respiratory protection.
The testimony of Exxon Mobils medical officials, as well as internal documents, established that the company was fully aware of the risk of disease posed by asbestos dust at its refinery properties as early as 1937, according to the plaintiff.
Christopher Andreas and Andrew Chew of the Novato, CA office of Brayton Purcell represented Merle Sandy at trial. San Francisco Superior Court Judge Gail Dekreon presided. The case is Merle Sandy v. Exxon Mobil Corporation (San Francisco Superior Court, No. 324212).
About Brayton Purcell:
For over 20 years, Brayton Purcell has helped clients protect their legal rights in the face of devastating losses such as illness, injuries, and harm to family members. The law firm enjoys a national reputation for the high quality of its personal injury and product liability work, particularly in the areas of asbestosis, asbestos colon cancer, asbestos lung cancer, mesothelioma and other asbestos diseases.
For more information, call 415-898-1555 or visit our firm web site at http://www.braytonlaw.com. For legal, legislative and medical news about mesothelioma and other asbestos cancers, see our specialty web sites, Asbestos Network at http://www.asbestosnetwork.com and Mesothelioma Network at http://www.mesotheliomasite.com
As you may have seen, the Mesothelioma Search Engine has finally moved out of development and into production. While there were many technical and design issues that were addressed in our first full project, Vioxx Search Engine, we ran into a few things that caused the project to be delayed longer than I would have liked. Still, it's better to release a good product late, than a poor product early, no matter how the success of Microsoft might indicate otherwise...!
The initial database of indexed sites is fairly small, but still returning pretty good results for most queries we have tested. I noticed about 6 times the site was book marked, and this must be from people that checked out the domain name and wanted to see if we were really going to be some kind of search engine, or another garden variety pseudo-information site, plastered with paid ads and mesothelioma lawyer links. To be sure we need to support the site and will have mesothelioma lawyer links as well if they contact us about advertising, but the main focus will just be on building the site content and returning good search results.
We do have one law firm that has agreed to work with any potential clients we may send them. I have checked into their background a little and they seem like they have the experience people will need and will care about them to some extent beyond the fees they earn from them. (hris